New drug effectively decreases recurrence of and death from endometrial cancer - News-Medical
New drug effectively decreases recurrence of and death from endometrial cancer News-Medical
Онкология
🎗️Лента новостей
Онкология
'Magic Drug' Reduces Risk of Death by 44% in Lung Cancer Trial
'Magic Drug' Reduces Risk of Death by 44% in Lung Cancer Trial MedPage Today
Онкология
UCL scientists design symbolic AI digital twins to treat cancer - News-Medical
UCL scientists design symbolic AI digital twins to treat cancer News-Medical
Онкология
CRIS Scientific Symposium and Awards 2027 – Next-Generation Precision Medicine in Cancer
CRIS Scientific Symposium and Awards 2027 – Next-Generation Precision Medicine in Cancer Oncodaily
Онкология
New treatment approach shows promise in reducing prostate cancer spread
Adding darolutamide to standard treatment for aggressive prostate cancer reduced the risk of the disease spreading in an international phase 3 trial.
Онкология
Tumor boards: What they are, how they work and why they matter
Tumor boards: What they are, how they work and why they matter UT MD Anderson
Онкология
Fructose slows liver tumors in mice when key sugar-processing gene is missing, may lead to new treatments
Fructose is an important nutrient that, despite having a chemical structure very similar to that of glucose, is metabolized very differently in the body. Research into fructose metabolism and its regulation of metabolism in the human body has in recent years become a frontier topic in the life sciences and medicine. A…
Онкология
Lung Cancer Blood Test May Help Predict Treatment Outcomes Before Surgery
Lung Cancer Blood Test May Help Predict Treatment Outcomes Before Surgery Inside Precision Medicine
Онкология
Breast Cancer Index influences extended endocrine therapy choice
Results from Breast Cancer Index testing prompted more than 40% of physicians to change extended endocrine therapy decisions for women with early-stage, hormone receptor-positive breast cancer. An analysis of nearly 3,000 patients found the number of physicians who reported high confidence in their decision-making…
Онкология
Biomarkers identified for cytokine release syndrome risk after CAR T-cell therapy
For patients with autoimmune disease, higher baseline B-cell counts and systemic inflammation are associated with development of cytokine release syndrome (CRS) after chimeric antigen receptor (CAR) T-cell therapy, according to a study published in the November issue of The Lancet Rheumatology.
Онкология
Immunotherapy combo extends survival for patients with aggressive small cell lung cancer, based on trial results
In patients with extensive-stage small cell lung cancer (ES-SCLC), tarlatamab, a bispecific T-cell engager, plus durvalumab as first-line maintenance therapy extended median overall survival by more than eight months, more than tripled progression-free survival and reduced the risk of death by 58% compared to…
